Artisan Partners’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$496M Buy
2,267,319
+71,836
+3% +$15.7M 0.73% 37
2025
Q1
$492M Sell
2,195,483
-915,420
-29% -$205M 0.79% 34
2024
Q4
$1.02B Buy
3,110,903
+44,376
+1% +$14.5M 1.53% 14
2024
Q3
$920M Buy
3,066,527
+574,635
+23% +$172M 1.37% 19
2024
Q2
$821M Buy
2,491,892
+425,355
+21% +$140M 1.23% 21
2024
Q1
$818M Buy
2,066,537
+105,474
+5% +$41.7M 1.18% 25
2023
Q4
$691M Buy
1,961,063
+369,792
+23% +$130M 1.06% 25
2023
Q3
$597M Buy
1,591,271
+578,796
+57% +$217M 1.01% 26
2023
Q2
$387M Sell
1,012,475
-152,234
-13% -$58.2M 0.62% 48
2023
Q1
$404M Buy
1,164,709
+103,905
+10% +$36M 0.66% 48
2022
Q4
$250M Buy
1,060,804
+145,065
+16% +$34.1M 0.44% 63
2022
Q3
$225M Buy
915,739
+62,491
+7% +$15.4M 0.4% 70
2022
Q2
$258M Buy
853,248
+308,549
+57% +$93.3M 0.44% 65
2022
Q1
$224M Sell
544,699
-218,495
-29% -$89.7M 0.3% 96
2021
Q4
$358M Sell
763,194
-36,174
-5% -$17M 0.42% 75
2021
Q3
$339M Sell
799,368
-191,826
-19% -$81.4M 0.41% 73
2021
Q2
$356M Sell
991,194
-259,005
-21% -$93M 0.42% 70
2021
Q1
$352M Sell
1,250,199
-50,836
-4% -$14.3M 0.45% 66
2020
Q4
$369M Sell
1,301,035
-56,760
-4% -$16.1M 0.45% 74
2020
Q3
$373M Buy
1,357,795
+806
+0.1% +$222K 0.53% 65
2020
Q2
$308M Buy
1,356,989
+156,444
+13% +$35.5M 0.49% 70
2020
Q1
$183M Buy
1,200,545
+99,512
+9% +$15.2M 0.39% 71
2019
Q4
$166M Buy
1,101,033
+25,769
+2% +$3.87M 0.29% 86
2019
Q3
$152M Sell
1,075,264
-9,560
-0.9% -$1.36M 0.29% 82
2019
Q2
$136M Sell
1,084,824
-26,641
-2% -$3.33M 0.25% 88
2019
Q1
$122M Buy
1,111,465
+5,052
+0.5% +$557K 0.24% 89
2018
Q4
$108M Sell
1,106,413
-8,836
-0.8% -$866K 0.24% 93
2018
Q3
$138M Sell
1,115,249
-58,032
-5% -$7.17M 0.26% 102
2018
Q2
$116M Sell
1,173,281
-72,584
-6% -$7.21M 0.23% 118
2018
Q1
$110M Buy
1,245,865
+243,421
+24% +$21.5M 0.22% 121
2017
Q4
$98.9M Buy
1,002,444
+160,360
+19% +$15.8M 0.19% 128
2017
Q3
$81.1M Buy
+842,084
New +$81.1M 0.15% 147